U. Kalyoncu Et Al. , "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA," European Congress of Rheumatology , vol.80, ELECTR NETWORK, pp.69-70, 2021
Kalyoncu, U. Et Al. 2021. TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA. European Congress of Rheumatology , (ELECTR NETWORK), 69-70.
Kalyoncu, U., Bilgin, E., Erden, A., Satis, H., Tufan, A., Tekgoz, E., ... Ates, A.(2021). TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA . European Congress of Rheumatology (pp.69-70). , ELECTR NETWORK
Kalyoncu, U. Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA," European Congress of Rheumatology, ELECTR NETWORK, 2021
Kalyoncu, U. Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." European Congress of Rheumatology , ELECTR NETWORK, pp.69-70, 2021
Kalyoncu, U. Et Al. (2021) . "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." European Congress of Rheumatology , ELECTR NETWORK, pp.69-70.
@conferencepaper{conferencepaper, author={U. Kalyoncu Et Al. }, title={TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA}, congress name={European Congress of Rheumatology}, city={}, country={ELECTR NETWORK}, year={2021}, pages={69-70} }